Cargando…
The cancer cell secretome drives cooperative manipulation of the tumour microenvironment to accelerate tumourigenesis
Cellular secretions are a fundamental aspect of cell–cell and cell–matrix interactions in vivo. In malignancy, cancer cells have an aberrant secretome compared to their non-malignant counterparts, termed the “cancer cell secretome”. The cancer cell secretome can influence every stage of the tumourig...
Autores principales: | Ritchie, Shona, Reed, Daniel A, Pereira, Brooke A, Timpson, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty Opinions Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894270/ https://www.ncbi.nlm.nih.gov/pubmed/33659922 http://dx.doi.org/10.12703/r/10-4 |
Ejemplares similares
-
Systemic muscle wasting and coordinated tumour response drive tumourigenesis
por: Newton, Holly, et al.
Publicado: (2020) -
Ras mutation cooperates with β-catenin activation to drive bladder tumourigenesis
por: Ahmad, I, et al.
Publicado: (2011) -
Tumourigenesis associated with the p53 tumour suppressor gene.
por: Chang, F., et al.
Publicado: (1993) -
Horizontal Gene Transfer of the Secretome Drives the Evolution of Bacterial Cooperation and Virulence
por: Nogueira, Teresa, et al.
Publicado: (2009) -
Overcoming the senescence‐associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer
por: Chambers, Cecilia R., et al.
Publicado: (2021)